Abstract
KCNQ5 is a highly conserved gene encoding an important channel for neuronal function; it is widely expressed in the brain and generates M-type current. Exome sequencing identified de novo heterozygous missense mutations in four probands with intellectual disability, abnormal neurological findings, and treatment-resistant epilepsy (in two of four). Comprehensive analysis of this potassium channel for the four variants expressed in frog oocytes revealed shifts in the voltage dependence of activation, including altered activation and deactivation kinetics. Specifically, both loss-of-function and gain-of-function KCNQ5 mutations, associated with increased excitability and decreased repolarization reserve, lead to pathophysiology.
Original language | English |
---|---|
Pages (from-to) | 65-74 |
Number of pages | 10 |
Journal | American journal of human genetics |
Volume | 101 |
Issue number | 1 |
DOIs | |
Publication status | Published - 6 Jul 2017 |
Keywords
- KCNQ5
- Kv7.5
- epilepsy
- epileptic encephalopathy
- intellectual disability
- potassium channels
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: American journal of human genetics, Vol. 101, No. 1, 06.07.2017, p. 65-74.
Research output: Contribution to journal › Article › Academic › peer-review
TY - JOUR
T1 - Loss-of-Function and Gain-of-Function Mutations in KCNQ5 Cause Intellectual Disability or Epileptic Encephalopathy
AU - CAUSES Study
AU - Lehman, Anna
AU - Thouta, Samrat
AU - Mancini, Grazia M.S.
AU - Naidu, Sakkubai
AU - van Slegtenhorst, Marjon
AU - McWalter, Kirsty
AU - Person, Richard
AU - Mwenifumbo, Jill
AU - Salvarinova, Ramona
AU - Adam, Shelin
AU - du Souich, Christèle
AU - Elliott, Alison M.
AU - Nelson, Tanya N.
AU - van Karnebeek, Clara
AU - Friedman, Jan M.
AU - Boelman, Cyrus
AU - Bolbocean, Corneliu
AU - Buerki, Sarah E.
AU - Candido, Tara
AU - Eydoux, Patrice
AU - Evans, Daniel M.
AU - Gibson, William
AU - Horvath, Gabriella
AU - Huh, Linda
AU - Sinclair, Graham
AU - Tarling, Tamsin
AU - Toyota, Eric B.
AU - Townsend, Katelin N.
AU - Van Allen, Margot I.
AU - Vercauteren, Suzanne
AU - Guella, Ilaria
AU - McKenzie, Marna B.
AU - Datta, Anita
AU - Connolly, Mary B.
AU - Kalkhoran, Somayeh Mojard
AU - Poburko, Damon
AU - Farrer, Matthew J.
AU - Demos, Michelle
AU - Desai, Sonal
AU - Claydon, Thomas
N1 - Funding Information: We thank the families for participating in this research. We thank the British Columbia Children’s Hospital (BCCH) BioBank, which is supported by Mining for Miracles through the BCCH Foundation. The bioinformatic pipeline used in the CAUSES study was developed in the laboratory of Wyeth Wasserman with intellectual contributions from Dave Arenillas, Phillip Richmond, Casper Shyr, Alison Matthews, and Maja Tarailo-Graovac. We are grateful for assistance from the BCCH Department of Pathology & Laboratory Medicine and the BCCH Electroencephalography Department. We thank Ji Qi and Jacob Kemp for expert technical assistance with functional-characterization experiments. The CAUSES study is funded by Mining for Miracles (BCCH Foundation) and Genome British Columbia with support from the British Columbia Provincial Health Services Authority and British Columbia Women’s Hospital . Functional studies were funded by the Rare Disease Foundation and a Natural Sciences and Engineering Research Council of Canada Discovery Grant. EPGEN is funded by the Canada Excellence Research Chair , Leading Edge Endowment Fund , Rare Disease Foundation , Grocholski Foundation , and Alva Foundation . Funding Information: We thank the families for participating in this research. We thank the British Columbia Children's Hospital (BCCH) BioBank, which is supported by Mining for Miracles through the BCCH Foundation. The bioinformatic pipeline used in the CAUSES study was developed in the laboratory of Wyeth Wasserman with intellectual contributions from Dave Arenillas, Phillip Richmond, Casper Shyr, Alison Matthews, and Maja Tarailo-Graovac. We are grateful for assistance from the BCCH Department of Pathology & Laboratory Medicine and the BCCH Electroencephalography Department. We thank Ji Qi and Jacob Kemp for expert technical assistance with functional-characterization experiments. The CAUSES study is funded by Mining for Miracles (BCCH Foundation) and Genome British Columbia with support from the British Columbia Provincial Health Services Authority and British Columbia Women's Hospital. Functional studies were funded by the Rare Disease Foundation and a Natural Sciences and Engineering Research Council of Canada Discovery Grant. EPGEN is funded by the Canada Excellence Research Chair, Leading Edge Endowment Fund, Rare Disease Foundation, Grocholski Foundation, and Alva Foundation. Publisher Copyright: © 2017 American Society of Human Genetics
PY - 2017/7/6
Y1 - 2017/7/6
N2 - KCNQ5 is a highly conserved gene encoding an important channel for neuronal function; it is widely expressed in the brain and generates M-type current. Exome sequencing identified de novo heterozygous missense mutations in four probands with intellectual disability, abnormal neurological findings, and treatment-resistant epilepsy (in two of four). Comprehensive analysis of this potassium channel for the four variants expressed in frog oocytes revealed shifts in the voltage dependence of activation, including altered activation and deactivation kinetics. Specifically, both loss-of-function and gain-of-function KCNQ5 mutations, associated with increased excitability and decreased repolarization reserve, lead to pathophysiology.
AB - KCNQ5 is a highly conserved gene encoding an important channel for neuronal function; it is widely expressed in the brain and generates M-type current. Exome sequencing identified de novo heterozygous missense mutations in four probands with intellectual disability, abnormal neurological findings, and treatment-resistant epilepsy (in two of four). Comprehensive analysis of this potassium channel for the four variants expressed in frog oocytes revealed shifts in the voltage dependence of activation, including altered activation and deactivation kinetics. Specifically, both loss-of-function and gain-of-function KCNQ5 mutations, associated with increased excitability and decreased repolarization reserve, lead to pathophysiology.
KW - KCNQ5
KW - Kv7.5
KW - epilepsy
KW - epileptic encephalopathy
KW - intellectual disability
KW - potassium channels
UR - http://www.scopus.com/inward/record.url?scp=85021327713&partnerID=8YFLogxK
U2 - https://doi.org/10.1016/j.ajhg.2017.05.016
DO - https://doi.org/10.1016/j.ajhg.2017.05.016
M3 - Article
C2 - 28669405
SN - 0002-9297
VL - 101
SP - 65
EP - 74
JO - American journal of human genetics
JF - American journal of human genetics
IS - 1
ER -